(Q37995020)

26 August 2017

Role of stemness-related molecules in neuroblastoma (English)

1 reference

26 August 2017

Takehiko Kamijo

1

1 reference

PubMed ID

22430387

26 August 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

71

1 reference

26 August 2017

4 Pt 2

1 reference

26 August 2017

511-515

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2011.54

26 August 2017

0 references

cites work

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Stem cell concepts renew cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Cancer stem cell: target for anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

A proposed staging for children with neuroblastoma.Children's cancer study group A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Characteristics of stem cells from human neuroblastoma cell lines and in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Polycomb silencers control cell fate, development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

AC133 expression in human stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.54

31 March 2020

Identifiers

DOI

10.1038/PR.2011.54

1 reference

26 August 2017

1 reference

PubMed ID

22430387